NA-AION Risk Factors: New Perspectives

Summary

The purpose of the study is to use new diagnostic methods (OCT and OCT-A) to shed light on risk factors for the development of NA-AION. The risk factors we are focusing on are comorbidities along with anatomical and vascular characteristics of the optic nerve.

Conditions

• Non-arteritic Ischemic Optic Neuropathy
• Optic Disk Drusen

Sponsors & Collaborators

• Velux Fonden

  collaborator OTHER

• Fight for Sight

  collaborator OTHER

• University of Copenhagen

  collaborator OTHER

• Hamilton Health Sciences Corporation

  collaborator OTHER

• Aarhus University Hospital

  collaborator OTHER

• Aalborg University Hospital

  collaborator OTHER

• Odense University Hospital

  collaborator OTHER

• Farabi Eye Hospital

  collaborator OTHER

• Wellington Hospital

  collaborator OTHER_GOV

• University of Colorado, Denver

  collaborator OTHER

• University of Utah

  collaborator OTHER

• London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  collaborator OTHER

• University of Sydney

  collaborator OTHER

• Stanford University

  collaborator OTHER

• Moorfields Eye Hospital NHS Foundation Trust

  collaborator OTHER

• Massachusetts Eye and Ear Infirmary

  collaborator OTHER

• University Hospital, Bordeaux

  collaborator OTHER

• Synoptik-Fonden

  collaborator UNKNOWN

• Rigshospitalet, Denmark

  lead OTHER

Principal Investigators

• Steffen Hamann · Rigshospitalet, Denmark

Eligibility

Min Age

11 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-08-01

Primary Completion

2024-08-31

Completion

2024-08-31

Countries

• United States
• Australia
• Canada
• Denmark
• France
• Iran
• Israel
• New Zealand
• United Kingdom

Study Locations